0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Dual Antiplatelet Therapy After Stent Implantation—Reply

Fausto Feres, MD, PhD1; Ricardo A. Costa, MD, PhD1; Deepak L. Bhatt, MD, MPH2
[+] Author Affiliations
1Instituto Dante Pazzanese de Cardiologia, São Paulo, São Paulo, Brazil
2Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts
JAMA. 2014;311(14):1446-1447. doi:10.1001/jama.2014.2107.
Text Size: A A A
Published online

Extract

In Reply The OPTIMIZE trial is the largest randomized trial published to date comparing short- vs long-term dual antiplatelet therapy after percutaneous coronary intervention. It was not meant to compare first- vs second-generation drug-eluting stents but rather to investigate the safety and efficacy of 3 vs 12 months of dual antiplatelet therapy with a second-generation drug-eluting stent. Over the past few years, several issues related to the duration of dual antiplatelet therapy have been studied and discussed in different clinical scenarios,1 which reflects the complexity of primary and secondary prevention of cardiovascular disease in daily clinical practice. However, in the context of percutaneous coronary intervention, there is substantial evidence demonstrating dissimilar vascular responses to different stent types, with significant implications for long-term safety.2,3 In fact, stent type alone was the single factor responsible for a change in guideline recommendations to prolong dual antiplatelet therapy.4 Thus, it appeared reasonable to perform a study comparing different dual antiplatelet therapy regimens using a second-generation drug-eluting stent.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

April 9, 2014
Stephen J. Greene, MD; Lora Alkhawam, MD; Muthiah Vaduganathan, MD, MPH
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
3Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
JAMA. 2014;311(14):1446. doi:10.1001/jama.2014.2092.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();